Janus Henderson Group plc 13D and 13G filings for Vaxcyte, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:12 pm Sale |
2024-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
10,575,363 8.500% |
-346,533 (-3.17%) |
Filing |
| 2024-11-14 2:53 pm Purchase |
2024-09-30 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
10,921,896 9.800% |
3,940,520 (+56.44%) |
Filing |
| 2024-02-13 2:10 pm Purchase |
2023-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
6,981,376 7.300% |
1,007,237 (+16.86%) |
Filing |
| 2023-02-10 12:06 pm Purchase |
2022-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
5,974,139 7.600% |
1,727,475 (+40.68%) |
Filing |
| 2022-02-10 5:24 pm Purchase |
2021-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
4,246,664 8.000% |
49,886 (+1.19%) |
Filing |
| 2021-02-12 3:52 pm Purchase |
2020-12-31 | 13G | Vaxcyte, Inc. PCVX |
JANUS HENDERSON GROUP PLC JHG |
4,196,778 8.200% |
4,196,778 (New Position) |
Filing |